Evidence map›Paper›PMID 21362154›Full record

ReviewActa physiologica (Oxford, England)2011

Neuronal and non-neuronal modulation of sympathetic neurovascular transmission.

H Macarthur, G H Wilken, T C Westfall, L L Kolo

Abstract readReview
In one paragraph

Review in Acta physiologica (Oxford, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. The effect of purinergic signaling via the PMolecular and cellular biochemistry · 2017
    Article
  10. ETAmerican journal of physiology. Regulatory, integrative and comparative physiology · 2017
    Article
  11. Article
  12. Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CBJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
  13. Review
  14. Article
  15. Article
  16. Blunted cerebral blood flow velocity in response to a nitric oxide donor in postural tachycardia syndrome.American journal of physiology. Heart and circulatory physiology · 2014
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

H MacarthurDepartment of Pharmacological and Physiological Science, Saint Louis University School of Medicine, MO 63104, USA. macarthu@slu.edu
G H Wilken
T C Westfall
L L Kolo
Saint Louis University · US

Funding

Pharmacological Sciences Training GrantT32GM008306 · NIGMS · SAINT LOUIS UNIVERSITY · PI EGAN, TERRANCE M, WALKER, JOHN K. · 1990 to 2020
$3.6M
NPY INDUCED REGULATION SYMPATHETIC NEUROTRANSMISSIONR01HL060260 · NHLBI · SAINT LOUIS UNIVERSITY · PI WESTFALL, THOMAS C · 1998 to 2006
$2.3M
DEACTIVATION OF CATECHOLAMINES BY NO, 02-, PEROXYNITRITR01HL061836 · NHLBI · SAINT LOUIS UNIVERSITY · PI MACARTHUR, HEATHER · 2000 to 2002
$629k
NHLBI NIH HHS HL60260NHLBI NIH HHS HL61836NHLBI NIH HHS R01 HL060260NHLBI NIH HHS R01 HL061836NIGMS NIH HHS GM083036NIGMS NIH HHS T32 GM008306
6 · The paper itself

Abstract

Noradrenaline, neuropeptide Y and adenosine triphosphate are co-stored in, and co-released from, sympathetic nerves. Each transmitter modulates its own release as well as the release of one another; thus, anything affecting the release of one of these transmitters has consequences for all. Neurotransmission at the sympathetic neurovascular junction is also modulated by non-sympathetic mediators such as angiotensin II, serotonin, histamine, endothelin and prostaglandins through the activation of specific pre-junctional receptors. In addition, nitric oxide (NO) has been identified as a modulator of sympathetic neuronal activity, both as a physiological antagonist against the vasoconstrictor actions of the sympathetic neurotransmitters, and also by directly affecting transmitter release. Here, we review the modulation of sympathetic neurovascular transmission by neuronal and non-neuronal mediators with an emphasis on the actions of NO. The consequences for co-transmission are also discussed, particularly in light of hypertensive states where NO availability is diminished.

Indexed as

AnimalsHumansNeuronsNeurotransmitter AgentsNitric OxideSympathetic Nervous SystemSynaptic TransmissionNeurotransmitter AgentsNitric Oxide

Identifiers

PMID21362154
PMCPMC3139802
OpenAlexW2136622917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.